Amlan Chakraborty

Amlan Chakraborty is Research Associate at the University of Manchester specializing in respiratory immunology and nanotherapeutics. His research develops innovative approaches to airway disease management through circadian biology and advanced drug delivery systems.

Research investigates nanoparticle-based immunomodulators for asthma control and pulmonary fibrosis reversal. Current projects explore steroid chronotherapy optimization and circadian regulation of airway hyperresponsiveness through epithelial clock genes.

Recognition includes European Respiratory Society Best Abstract Award and Paolo Sassone-Corsi Award for circadian biology research. Community engagement includes science outreach programs for school children.